Saudia Dairy & Foodstuff Company (TADAWUL:2270)
275.80
+3.80 (1.40%)
Aug 12, 2025, 3:10 PM AST
Elevation Oncology Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Revenue | 3,087 | 2,963 | 2,780 | 2,648 | 2,170 | 2,105 | Upgrade |
Revenue Growth (YoY) | 7.47% | 6.59% | 4.97% | 22.01% | 3.08% | 2.40% | Upgrade |
Cost of Revenue | 2,006 | 1,908 | 1,830 | 1,828 | 1,528 | 1,423 | Upgrade |
Gross Profit | 1,081 | 1,055 | 949.93 | 819.89 | 642.59 | 682.49 | Upgrade |
Selling, General & Admin | 635 | 591.56 | 516.73 | 462.09 | 410.82 | 403.85 | Upgrade |
Other Operating Expenses | -3.16 | -2.21 | -2.35 | -1.8 | -5.64 | -8.93 | Upgrade |
Operating Expenses | 624.28 | 586.31 | 503.66 | 448.88 | 406.38 | 397.02 | Upgrade |
Operating Income | 456.86 | 468.26 | 446.27 | 371.01 | 236.21 | 285.46 | Upgrade |
Interest Expense | -1.31 | -2.68 | -18.77 | -2.48 | -2.57 | -7.77 | Upgrade |
Interest & Investment Income | 44.46 | 49.69 | 40.23 | 18.5 | 4.4 | 6.16 | Upgrade |
Earnings From Equity Investments | - | - | 0.86 | -0.39 | 0.97 | - | Upgrade |
Other Non Operating Income (Expenses) | -8.2 | -8.2 | -1.9 | -47.53 | -4.74 | - | Upgrade |
EBT Excluding Unusual Items | 491.81 | 507.06 | 466.68 | 339.12 | 234.27 | 283.86 | Upgrade |
Impairment of Goodwill | - | - | -15.75 | - | - | - | Upgrade |
Asset Writedown | - | - | -0.15 | - | - | - | Upgrade |
Pretax Income | 491.81 | 507.06 | 450.78 | 339.12 | 234.27 | 283.86 | Upgrade |
Income Tax Expense | 18.87 | 23.9 | 36.07 | 28.65 | 25.22 | 22.96 | Upgrade |
Earnings From Continuing Operations | 472.94 | 483.16 | 414.71 | 310.46 | 209.05 | 260.89 | Upgrade |
Minority Interest in Earnings | 0.48 | 0.52 | 3.35 | -1.69 | -1.76 | -0.34 | Upgrade |
Net Income | 473.42 | 483.69 | 418.06 | 308.77 | 207.29 | 260.55 | Upgrade |
Net Income to Common | 473.42 | 483.69 | 418.06 | 308.77 | 207.29 | 260.55 | Upgrade |
Net Income Growth | 0.06% | 15.70% | 35.39% | 48.95% | -20.44% | -2.14% | Upgrade |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 32 | Upgrade |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 32 | Upgrade |
EPS (Basic) | 14.79 | 15.12 | 13.06 | 9.65 | 6.48 | 8.14 | Upgrade |
EPS (Diluted) | 14.79 | 15.12 | 13.06 | 9.65 | 6.48 | 8.14 | Upgrade |
EPS Growth | 0.06% | 15.70% | 35.39% | 48.95% | -20.44% | -2.14% | Upgrade |
Free Cash Flow | 486.13 | 265.93 | 659.56 | 288.11 | 122.95 | 262.19 | Upgrade |
Free Cash Flow Per Share | 15.19 | 8.31 | 20.61 | 9.00 | 3.84 | 8.19 | Upgrade |
Dividend Per Share | 9.000 | 15.000 | 16.000 | 6.000 | 6.000 | 6.000 | Upgrade |
Dividend Growth | -59.09% | -6.25% | 166.67% | - | - | 20.00% | Upgrade |
Gross Margin | 35.02% | 35.59% | 34.17% | 30.96% | 29.61% | 32.42% | Upgrade |
Operating Margin | 14.80% | 15.80% | 16.05% | 14.01% | 10.88% | 13.56% | Upgrade |
Profit Margin | 15.34% | 16.32% | 15.04% | 11.66% | 9.55% | 12.38% | Upgrade |
Free Cash Flow Margin | 15.75% | 8.97% | 23.73% | 10.88% | 5.67% | 12.45% | Upgrade |
EBITDA | 557.82 | 570.8 | 551.22 | 477.4 | 328.51 | 374.17 | Upgrade |
EBITDA Margin | 18.07% | 19.27% | 19.83% | 18.03% | 15.14% | 17.77% | Upgrade |
D&A For EBITDA | 100.96 | 102.54 | 104.96 | 106.38 | 92.3 | 88.71 | Upgrade |
EBIT | 456.86 | 468.26 | 446.27 | 371.01 | 236.21 | 285.46 | Upgrade |
EBIT Margin | 14.80% | 15.80% | 16.05% | 14.01% | 10.88% | 13.56% | Upgrade |
Effective Tax Rate | 3.84% | 4.71% | 8.00% | 8.45% | 10.77% | 8.09% | Upgrade |
Advertising Expenses | - | 145.54 | - | 74.7 | 47.4 | 45.19 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.